Address :132-A BUSINESS CENTER DR CORONA, CA, 92880-1724 UNITED STATES | |||
Status : A | Type : A | Woman Owned : N | Business Type : N |
Business Size : A | Primary Business : J | CAO Code : S0513A | ADP Code : HQ0339 |
Part No | Item Name | Manufacturer | NSN | QTY | RFQ |
---|---|---|---|---|---|
NDC52544-0596-01 | clomipramine hydrochloride capsules | Watson Labs Inc | 6505-01-318-7402 | Avl | RFQ |
NDC00536-3414-10 | calcium carbonate tablets usp | Watson Labs Inc | 6505-00-502-7835 | Avl | RFQ |
NDC52544-0381-01 | amoxapine tablets u | Watson Labs Inc | 6505-01-111-3194 | Avl | RFQ |
NDC52544-0372-01 | loxapine capsules usp | Watson Labs Inc | 6505-01-190-6285 | Avl | RFQ |
NDC00591-5059-10 | prednisolone tablets usp | Watson Labs Inc | 6505-01-235-1382 | Avl | RFQ |
NDC52544-0371-10 | loxapine capsules usp | Watson Labs Inc | 6505-01-048-3719 | Avl | RFQ |
NDC00364-2465-34 | cefazolin injection | Watson Labs Inc | 6505-01-480-2501 | Avl | RFQ |
NDC00591-0460-05 | glipizide tablets usp | Watson Labs Inc | 6505-01-244-9942 | Avl | RFQ |
NDC52544-0787-05 | chlordiazepoxide hydrochloride c | Watson Labs Inc | 6505-00-059-9019 | Avl | RFQ |
NDC52544-0460-05 | glipizide tablets usp | Watson Labs Inc | 6505-01-244-9942 | Avl | RFQ |
NDC00591-2229-05 | metoclopramide tabl | Watson Labs Inc | 6505-01-124-3800 | Avl | RFQ |
NDC00591-5052-10 | prednisone tablets usp | Watson Labs Inc | 6505-00-530-6470 | Avl | RFQ |
NDC00536-4075-01 | niacin extended release capsules | Watson Labs Inc | 6505-01-169-7487 | Avl | RFQ |
NDC16252-0591-99 | sumatriptan succinate tablets | Watson Labs Inc | 6505-01-456-2497 | Avl | RFQ |
NDC52544-0812-01 | loxapine capsules usp | Watson Labs Inc | 6505-01-200-5786 | Avl | RFQ |
NDC00591-2520-05 | chlorzoxazone tablets usp | Watson Labs Inc | 6505-01-315-5359 | Avl | RFQ |
NDC52544-0801-05 | hydroxyzine pamoate capsules usp | Watson Labs Inc | 6505-00-765-0824 | Avl | RFQ |
NDC00591-3465-01 | ibuprofen tablets u | Watson Labs Inc | 6505-01-146-5130 | Avl | RFQ |
NDC00591-0338-60 | diclofenac sodium extended relea | Watson Labs Inc | 6505-01-296-3173 | Avl | RFQ |
NDC00591-0491-01 | mexiletine hydrochloride capsule | Watson Labs Inc | 6505-01-256-6367 | Avl | RFQ |
NDC52544-0814-10 | loxapine capsules usp | Watson Labs Inc | 6505-01-048-3718 | Avl | RFQ |
NDC52544-0682-01 | alprazolam tablets usp | Watson Labs Inc | 6505-01-143-9269 | Avl | RFQ |
NDC52544-0716-10 | quinine sulfate capsules usp | Watson Labs Inc | 6505-01-042-8040 | Avl | RFQ |
NDC52544-0395-01 | pentazocine and naloxone hydorch | Watson Labs Inc | 6505-00-180-6030 | Avl | RFQ |
NDC00591-0416-01 | estropipate tablets usp | Watson Labs Inc | 6505-01-214-8733 | Avl | RFQ |
NDC52544-0815-34 | loxapine hydrochloride oral solu | Watson Labs Inc | 6505-01-026-0101 | Avl | RFQ |
NDC52544-0792-01 | naproxen sodium tab | Watson Labs Inc | 6505-01-155-5157 | Avl | RFQ |
NDC52544-0575-10 | trihexyphenidyl hydrochloride tablets usp | Watson Labs Inc | 6505-01-153-3963 | Avl | RFQ |
NDC00591-3465-05 | ibuprofen tablets u | Watson Labs Inc | 6505-01-098-0247 | Avl | RFQ |
NDC52544-0496-01 | loxapine capsules u | Watson Labs Inc | 6505-01-156-2044 | Avl | RFQ |
NDC52544-0447-03 | fluocinonide cream | Watson Labs Inc | 6505-01-147-9552 | Avl | RFQ |
NDC00591-0775-01 | diltiazem tablets u | Watson Labs Inc | 6505-01-145-8825 | Avl | RFQ |
NDC52544-0308-05 | propranolol hydrochloride tablet | Watson Labs Inc | 6505-01-376-6535 | Avl | RFQ |
NDC52544-0782-01 | diethylpropion hydrochloride extended release tabl | Watson Labs Inc | 6505-01-234-9586 | Avl | RFQ |
NDC52544-0697-10 | doxepin hydrochloride capsules u | Watson Labs Inc | 6505-00-405-9261 | Avl | RFQ |
NDC52544-0469-60 | testosterone transdermal system | Watson Labs Inc | 6505-01-423-4981 | Avl | RFQ |
NDC00591-0810-85 | sulfadiazine silver cream | Watson Labs Inc | 6505-01-280-4733 | Avl | RFQ |
C0RDRAN | flurandrenolide cre | Watson Labs Inc | 6505-00-890-1554 | Avl | RFQ |
NDC52544-0545-01 | desipramine hydroch | Watson Labs Inc | 6505-01-160-7722 | Avl | RFQ |
NDC00591-5522-05 | hydroxyzine hydrochloride tablet | Watson Labs Inc | 6505-00-579-9715 | Avl | RFQ |
NDC52544-0810-85 | sulfadiazine silver | Watson Labs Inc | 6505-01-280-4733 | Avl | RFQ |
NDC00591-0369-01 | loxapine capsules usp | Watson Labs Inc | 6505-01-270-5970 | Avl | RFQ |
NDC00536-1372-06 | nicotine polacrilex gum usp | Watson Labs Inc | 6505-01-598-4571 | Avl | RFQ |
NDC52544-0664-10 | diltiazem extended release capsu | Watson Labs Inc | 6505-01-393-7437 | Avl | RFQ |
NDC52544-0349-01 | hydrocodone bitartrate and aceta | Watson Labs Inc | 6505-01-189-9903 | Avl | RFQ |
NDC52544-0345-05 | verapamil hydrochlo | Watson Labs Inc | 6505-01-231-7276 | Avl | RFQ |
NDC52544-0418-05 | cyclobenzaprine hydrochloride ta | Watson Labs Inc | 6505-01-356-3877 | Avl | RFQ |
NDC52544-0931-02 | iron dextran injection usp | Watson Labs Inc | 6505-01-362-8314 | Avl | RFQ |
NDC52544-0301-05 | furosemide tablets usp | Watson Labs Inc | 6505-00-254-5546 | Avl | RFQ |
NDC52544-0716-01 | quinine sulfate capsules usp | Watson Labs Inc | 6505-00-957-9532 | Avl | RFQ |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
Don’t forget That We offer Same-Day Shipping and 24/7 Service for Our Customers.
Request for Quote